Compositions and methods to reduce beta-agonist-mediated tachyphylaxis
US10927375B1 · kind B1 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 31, 2019 |
| Grant date | Feb 23, 2021 |
| Priority date | — |
| Expiry date | Jan 31, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are let-7f miRNA inhibitors and uses thereof. In some embodiments, the let-7f miRNA inhibitors can be capable of reducing method of reducing β-agonist-mediated β2-Adrenergic Receptor (β2AR) down regulation in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.